The Patient’s Journey in Obesity within the United States: An Exercise of Resilience against Disease
Abstract
:1. Introduction
2. Weight Gain and Early Intervention
3. A Cultural Shift toward Acceptance
4. Health at Every Size
5. Mistrust in Healthcare
6. Dietary Changes and Physical Activity
7. Pharmacotherapy
8. Barriers to Pharmacotherapy
9. Metabolic and Bariatric Surgery (MBS)
10. Conclusions
Funding
Conflicts of Interest
References
- Obesity and Overweight. Available online: https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight#:~:text=Obesity%20is%20a%20chronic%20complex,the%20risk%20of%20certain%20cancers (accessed on 31 March 2024).
- Narayan, A.; Agarwal, A.A.; Stanford, C.F. Challenges with Relying on Body Fat and Weight Values for Obesity—Reply. JAMA Intern. Med. 2024, 184, 990–991. [Google Scholar] [CrossRef] [PubMed]
- Overweight and Obesity. Available online: https://www.cdc.gov/obesity/php/about/index.html (accessed on 1 June 2024).
- Waldrop, W.S.; Johnson, R.V.; Stanford, C.F. Inequalities in the provision of GLP-1 receptor agonists for the treatment of obesity. Nat. Med. 2024, 30, 22–25. [Google Scholar] [CrossRef]
- Kyle, K.T.; Nadglowski, F.J.; Stanford, C.F. Weight Management and Healthy Lifestyles. JAMA Intern. Med. 2020, 180, 1403. [Google Scholar] [CrossRef] [PubMed]
- Claridy, D.M.; Czepiel, S.K.; Bajaj, S.S.; Stanford, C.F. Treatment of Obesity: Pharmacotherapy Trends of Office-Based Visits in the United States from 2011 to 2016. Mayo Clin. Proc. 2021, 96, 2991–3000. [Google Scholar] [CrossRef] [PubMed]
- What Are Overweight and Obesity? Available online: https://www.nichd.nih.gov/health/topics/obesity/conditioninfo/cause (accessed on 1 June 2024).
- Ghosh, S.; Bouchard, C. Convergence between biological, behavioural and genetic determinants of obesity. Nat. Rev. Genet. 2017, 18, 731–748. [Google Scholar] [CrossRef]
- Laddu, D.; Neeland, J.I.; Carnethon, M.; Stanford, C.F.; Mongraw-Chaffin, M.; Gibbs, B.B.; Ndumele, E.C.; Longenecker, T.C.; Chung, L.M.; Rao, G. Implementation of Obesity Science into Clinical Practice: A Scientific Statement from the American Heart Association. Circulation 2024, 150, e7–e19. [Google Scholar] [CrossRef]
- Washington, B.T.; Johnson, R.V.; Kendrick, K.; Ibrahim, A.A.; Tu, L.; Sun, K.; Stanford, C.F. Disparities in Access and Quality of Obesity Care. Gastroenterol. Clin. N. Am. 2023, 52, 429–441. [Google Scholar] [CrossRef]
- Hite, A.; Victorson, D.; Elue, R.; Plunkett, B.A. An Exploration of Barriers Facing Physicians in Diagnosing and Treating Obesity. Am. J. Health Promot. 2019, 33, 217–224. [Google Scholar] [CrossRef]
- Haqq, A.M.; Kebbe, M.; Tan, Q.; Manco, M.; Salas, X.R. Complexity and Stigma of Pediatric Obesity. Child. Obes. 2021, 17, 229–240. [Google Scholar] [CrossRef]
- Stanford, C.F. A new era in obesity management. Nat. Rev. Gastroenterol. Hepatol. 2024, 21, 80–81. [Google Scholar] [CrossRef]
- Olson, A.; Stanford, C.F.; Butsch, S.W. Obesity in the USMLE Step 1 examination: A call to action. Int. J. Obes. 2023, 47, 642–643. [Google Scholar] [CrossRef] [PubMed]
- Penney, T.L.; Kirk, S.F. The Health at Every Size paradigm and obesity: Missing empirical evidence may help push the reframing obesity debate forward. Am. J. Public Health 2015, 105, e38–e42. [Google Scholar] [CrossRef] [PubMed]
- McWhorter, K.L. Obesity Acceptance: Body Positivity and Clinical Risk Factors. In Cardiac Diseases—Novel Aspects of Cardiac Risk, Cardiorenal Pathology and Cardiac Interventions; IntechOpen: London, UK, 2020. [Google Scholar] [CrossRef]
- Cohen, R.; Newton-John, T.; Slater, A. The case for body positivity on social media: Perspectives on current advances and future directions. J. Health Psychol. 2021, 26, 2365–2373. [Google Scholar] [CrossRef]
- Muttarak, R. Normalization of Plus Size and the Danger of Unseen Overweight and Obesity in England. Obesity 2018, 26, 1125–1129. [Google Scholar] [CrossRef]
- Rasmussen, W.D. The Rights/Development Nexus: Sen, Olson, and the Obesity Rights Movement. Soc. Sci. Q. 2019, 100, 923–935. [Google Scholar] [CrossRef]
- NAAFA. About Us. Available online: https://naafa.org/aboutus (accessed on 1 June 2024).
- Kirkland, A. Think of the Hippopotamus: Rights Consciousness in the Fat Acceptance Movement. Law Soc. Rev. 2008, 42, 397–432. [Google Scholar] [CrossRef]
- Reyes, C.J.K.; Sabharwal, S.; Stanford, C.F. Legal Evolution of a Law against Weight Discrimination in the United States: A Focus on Massachusetts. Am. J. Health Promot. 2023, 37, 164–167. [Google Scholar] [CrossRef]
- Sabharwal, S.; Reyes, C.J.K.; Stanford, C.F. Need for Legal Protection against Weight Discrimination in the United States. Obesity 2020, 28, 1784–1785. [Google Scholar] [CrossRef]
- Lucassen, A.E.; Cizza, G. The Hypothalamic-Pituitary-Adrenal Axis, Obesity, and Chronic Stress Exposure: Sleep and the HPA Axis in Obesity. Curr. Obes. Rep. 2012, 1, 208–215. [Google Scholar] [CrossRef]
- Dimitrov Ulian, M.; Pinto, A.J.; de Morais Sato, P.; Benatti, F.B.; Lopes de Campos-Ferraz, P.; Coelho, D.; Roble, O.J.; Sabatini, F.; Perez, I.; Aburad, L.; et al. Effects of new intervention based on Health at Every Size approach for the management of obesity: The “Health and Wellness in Obesity” study. PLoS ONE 2018, 13, e0198401. [Google Scholar] [CrossRef] [PubMed]
- Williamson, D.L.; Bigman, A.C. A systematic review of medical mistrust measures. Patient Educ. Couns. 2018, 101, 1786–1794. [Google Scholar] [CrossRef]
- Bajaj, S.S.; Stanford, C.F. Beyond Tuskegee—Vaccine Distrust and Everyday Racism. N. Engl. J. Med. 2021, 384, e12. [Google Scholar] [CrossRef] [PubMed]
- Stimpson, P.J.; Ortega, N.A. Social media users’ perceptions about health mis- and disinformation on social media. Health Aff. Sch. 2023, 1, qxad050. [Google Scholar] [CrossRef] [PubMed]
- Stanford, C.F.; Tauqeer, Z.; Kyle, K.T. Media and Its Influence on Obesity. Curr. Obes. Rep. 2018, 7, 186–192. [Google Scholar] [CrossRef] [PubMed]
- Park, J.Y.; Chung, E.J.; Kim, N.J. Social media, misinformation, and cultivation of informational mistrust: Cultivating COVID-19 mistrust. Journalism 2022, 23, 2571–2590. [Google Scholar] [CrossRef]
- Nah, S.; Williamson, D.L.; Kahlor, A.L.; Atkinson, L.; Upshaw, J.S.; Ntang-Beb, J.-L. The Roles of Social Media Use and Medical Mistrust in Black Americans’ COVID-19 Vaccine Hesitancy: The RISP Model Perspective. Health Commun. 2023, 39, 1833–1846. [Google Scholar] [CrossRef]
- Parmar, R.M.; Can, A.S. Dietary Approaches to Obesity Treatment; StatPearls: Treasure Island, FL, USA, 2024. [Google Scholar]
- Chae, K.; German, J.; Kendrick, K.; Tackett, S.; O’Rourke, P.; Gudzune, K.A.; Laudenslager, M. An obesity medicine curriculum increases the obesity care self-efficacy of internal medicine residents in the primary care setting. Clin. Obes. 2024, 14, e12656. [Google Scholar] [CrossRef]
- Conaty, E.A.; Denham, W.; Haggerty, S.P.; Linn, J.G.; Joehl, R.J.; Ujiki, M.B. Primary Care Physicians’ Perceptions of Bariatric Surgery and Major Barriers to Referral. Obes. Surg. 2020, 30, 521–526. [Google Scholar] [CrossRef]
- Bosch-Sierra, N.; Grau-Del Valle, C.; Salom, C.; Zaragoza-Villena, B.; Perea-Galera, L.; Falcon-Tapiador, R.; Rovira-Llopis, S.; Morillas, C.; Monleon, D.; Banuls, C. Effect of a Very Low-Calorie Diet on Oxidative Stress, Inflammatory and Metabolomic Profile in Metabolically Healthy and Unhealthy Obese Subjects. Antioxidants 2024, 13, 302. [Google Scholar] [CrossRef]
- Ravussin, E.; Redman, M.L. Metabolic adaptation: Is it really an illusion? Am. J. Clin. Nutr. 2020, 112, 1653–1654. [Google Scholar] [CrossRef] [PubMed]
- Gadde, K.M.; Atkins, K.D. The limits and challenges of antiobesity pharmacotherapy. Expert Opin. Pharmacother. 2020, 21, 1319–1328. [Google Scholar] [CrossRef] [PubMed]
- Wang, J.-Y.; Wang, Q.-W.; Yang, X.-Y.; Yang, W.; Li, D.-R.; Jin, J.-Y.; Zhang, H.-C.; Zhang, X.-F. GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach. Front. Endocrinol. 2023, 14, 1085799. [Google Scholar] [CrossRef]
- Lincoff, M.A.; Brown-Frandsen, K.; Colhoun, M.H.; Deanfield, J.; Emerson, S.S.; Esbjerg, S.; Hardt-Lindberg, S.; Hovingh, K.G.; Kahn, E.S.; Kushner, F.R.; et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N. Engl. J. Med. 2023, 389, 2221–2232. [Google Scholar] [CrossRef] [PubMed]
- Vilar-Gomez, E.; Martinez-Perez, Y.; Calzadilla-Bertot, L.; Torres-Gonzalez, A.; Gra-Oramas, B.; Gonzalez-Fabian, L.; Friedman, L.S.; Diago, M.; Romero-Gomez, M. Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis. Gastroenterology 2015, 149, 367–378.e5. [Google Scholar] [CrossRef] [PubMed]
- Prasad, R.; Jha, K.R.; Keerti, A. Chronic Kidney Disease: Its Relationship with Obesity. Cureus 2022, 14, e30535. [Google Scholar] [CrossRef]
- FDA. FDA Approves First Treatment to Reduce Risk of Serious Heart Problems Specifically in Adults with Obesity or Overweight. 2024. Available online: https://www.fda.gov/news-events/press-announcements/fda-approves-first-treatment-reduce-risk-serious-heart-problems-specifically-adults-obesity-or#:~:text=Today%2C%20the%20U.S.%20Food%20and,and%20either%20obesity%20or%20overweight (accessed on 1 June 2024).
- Lim, Z.Y.; Wong, J.; Hussain, M.S.; Estee, M.M.; Zolio, L.; Page, J.M.; Harrison, L.C.; Wluka, E.A.; Wang, Y.; Cicuttini, M.F. Recommendations for weight management in osteoarthritis: A systematic review of clinical practice guidelines. Osteoarthr. Cartil. Open 2022, 4, 100298. [Google Scholar] [CrossRef]
- Fornes, A.; Huff, J.; Pritchard, I.R.; Godfrey, M. Once-Weekly Semaglutide for Weight Management: A Clinical Review. J. Pharm. Technol. 2022, 38, 239–246. [Google Scholar] [CrossRef]
- Mehta, A.; Marso, P.S.; Neeland, J.I. Liraglutide for weight management: A critical review of the evidence. Obes. Sci. Pract. 2017, 3, 3–14. [Google Scholar] [CrossRef]
- Balasanthiran, A.; Munro, N.; Watters, K.; Poots, A.; Morganstein, D.; Feher, M. Liraglutide withdrawal rates: ‘real world’ practice. Pract. Diabetes 2012, 29, 144–146. [Google Scholar] [CrossRef]
- Jastreboff, M.A.; Aronne, J.L.; Ahmad, N.N.; Wharton, S.; Connery, L.; Alves, B.; Kiyosue, A.; Zhang, S.; Liu, B.; Bunck, C.M.; et al. Tirzepatide Once Weekly for the Treatment of Obesity. N. Engl. J. Med. 2022, 387, 205–216. [Google Scholar] [CrossRef]
- Kim, N.T. Barriers to Obesity Management: Patient and Physician Factors. J. Obes. Metab. Syndr. 2020, 29, 244–247. [Google Scholar] [CrossRef] [PubMed]
- Wilson, R.E.; Kyle, K.T.; Nadglowski, F.J.; Stanford, C.F. Obesity coverage gap: Consumers perceive low coverage for obesity treatments even when workplace wellness programs target BMI. Obesity 2017, 25, 370–377. [Google Scholar] [CrossRef] [PubMed]
- Constantino, A. Here’s How Much People Are Willing to Spend on Weight Loss Drugs, According to a New Survey. Available online: https://www.cnbc.com/2024/03/23/weight-loss-drug-cost-how-much-people-are-willing-to-spend.html#:~:text=A%20monthly%20package%20of%20a,patient%20has%20commercial%20insurance%20coverage (accessed on 1 June 2024).
- Kendrick, N.K.; Marcondes, O.F.; Stanford, C.F.; Mukamal, J.K. Medicaid expansion and health care access for individuals with obesity in the United States. Obesity 2022, 30, 1787–1795. [Google Scholar] [CrossRef]
- Salzbrenner, S.G.; Lydiatt, M.; Helding, B.; Scheier, L.M.; Greene, H.; Hill, P.W.; McAdam-Marx, C. Influence of prior authorization requirements on provider clinical decision-making. Am. J. Manag. Care 2023, 29, 331–337. [Google Scholar] [CrossRef]
- Agarwal, A.A.; Narayan, A.; Stanford, C.F. Body Composition in Anti-Obesity Medication Trials—Beyond Scales. JAMA Intern. Med. 2024, 184, 341. [Google Scholar] [CrossRef]
- OMA. Leading Obesity Expert Organizations Release Statement to Patients on Compounded GLP-1 Alternatives. 2024. Available online: https://obesitymedicine.org/blog/leading-obesity-expert-organizations-release-statement-to-patients-on-glp-1-compounded-alternatives/ (accessed on 1 June 2024).
- Eisenberg, D.; Shikora, A.S.; Aarts, E.; Aminian, A.; Angrisani, L.; Cohen, V.R.; Luca, D.M.; Faria, L.S.; Goodpaster, P.S.K.; Haddad, A.; et al. 2022 American Society for Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO): Indications for Metabolic and Bariatric Surgery. Surg. Obes. Relat. Dis. 2022, 18, 1345–1356. [Google Scholar] [CrossRef]
- Keyte, R.; Mantzios, M.; Hussain, M.; Tahrani, A.A.; Abbott, S.; Strachan, R.; Singhal, R.; Egan, H. ‘Surgery is my only hope’: A qualitative study exploring perceptions of living with obesity and the prospect of having bariatric surgery. Clin. Obes. 2024, 14, e12643. [Google Scholar] [CrossRef]
- Stanford, C.F.; Kyle, K.T.; Claridy, D.M.; Nadglowski, F.J.; Apovian, M.C. The influence of an individual’s weight perception on the acceptance of bariatric surgery. Obesity 2015, 23, 277–281. [Google Scholar] [CrossRef] [PubMed]
- Malhotra, S.; Czepiel, S.K.; Akam, Y.E.; Shaw, Y.A.; Sivasubramanian, R.; Seetharaman, S.; Stanford, C.F. Bariatric surgery in the treatment of adolescent obesity: Current perspectives in the United States. Expert Rev. Endocrinol. Metab. 2021, 16, 123–134. [Google Scholar] [CrossRef]
- Reyes, C.J.K.; Misra, M.; Lee, H.; Stanford, C.F. Weight Loss Surgery Utilization in Patients Aged 14–25 with Severe Obesity among Several Healthcare Institutions in the United States. Front. Pediatr. 2018, 6, 251. [Google Scholar] [CrossRef]
- Perez, P.N.; Stanford, C.F.; Chang, C.D. Comment on: Socioecological factors associated with metabolic and bariatric surgery utilization: A qualitative study in an ethnically diverse sample. Surg. Obes. Relat. Dis. 2020, 16, 795–797. [Google Scholar] [CrossRef] [PubMed]
- Stanford, C.F.; Mushannen, T.; Cortez, P.; Reyes, C.J.K.; Lee, H.; Gee, W.D.; Pratt, S.J.; Boepple, A.P.; Bredella, A.M.; Misra, M.; et al. Comparison of Short and Long-Term Outcomes of Metabolic and Bariatric Surgery in Adolescents and Adults. Front. Endocrinol. 2020, 11, 157. [Google Scholar] [CrossRef]
- Noria, F.S.; Shelby, D.R.; Atkins, D.K.; Nguyen, T.N.; Gadde, M.K. Weight Regain after Bariatric Surgery: Scope of the Problem, Causes, Prevention, and Treatment. Curr. Diabetes Rep. 2023, 23, 31–42. [Google Scholar] [CrossRef] [PubMed]
- Akpinar, E.O.; Liem, R.S.L.; Nienhuijs, S.W.; Greve, J.W.M.; Marang-van de Mheen, P.J.; Dutch Audit for Treatment of Obesity Research Group. Weight recurrence after Sleeve Gastrectomy versus Roux-en-Y gastric bypass: A propensity score matched nationwide analysis. Surg. Endosc. 2023, 37, 4351–4359. [Google Scholar] [CrossRef]
- Stanford, C.F.; Alfaris, N.; Gomez, G.; Ricks, T.E.; Shukla, P.A.; Corey, E.K.; Pratt, S.J.; Pomp, A.; Rubino, F.; Aronne, J.L. The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: A multi-center study. Surg. Obes. Relat. Dis. 2017, 13, 491–500. [Google Scholar] [CrossRef]
- Stanford, C.F.; Toth, T.A.; Shukla, P.A.; Pratt, S.J.; Cena, H.; Biino, G.; Aronne, J.L. Weight Loss Medications in Older Adults after Bariatric Surgery for Weight Regain or Inadequate Weight Loss: A Multicenter Study. Bariatr. Surg. Pract. Patient Care 2018, 13, 171–178. [Google Scholar] [CrossRef] [PubMed]
- Stanford, C.F. Controversial issues: A practical guide to the use of weight loss medications after bariatric surgery for weight regain or inadequate weight loss. Surg. Obes. Relat. Dis. 2019, 15, 128–132. [Google Scholar] [CrossRef]
- ASMBS. Estimate of Bariatric Surgery Numbers, 2011–2022. Available online: https://asmbs.org/resources/estimate-of-bariatric-surgery-numbers/ (accessed on 1 June 2024).
- Toth, A.; Gomez, G.; Shukla, A.; Pratt, J.; Cena, H.; Biino, G.; Aronne, L.; Stanford, F. Weight Loss Medications in Young Adults after Bariatric Surgery for Weight Regain or Inadequate Weight Loss: A Multi-Center Study. Children 2018, 5, 116. [Google Scholar] [CrossRef]
- Gazda, L.C.; Clark, D.J.; Lingvay, I.; Almandoz, P.J. Pharmacotherapies for Post-Bariatric Weight Regain: Real-World Comparative Outcomes. Obesity 2021, 29, 829–836. [Google Scholar] [CrossRef]
- Anekwe, V.C.; Knight, G.M.; Seetharaman, S.; Dutton, P.W.; Chhabria, M.S.; Stanford, C.F. Pharmacotherapeutic Options for Weight Regain after Bariatric Surgery. Curr. Treat. Options Gastroenterol. 2021, 19, 524–541. [Google Scholar] [CrossRef]
- Stanford, C.F.; Kyle, K.T. Why food policy and obesity policy are not synonymous: The need to establish clear obesity policy in the United States. Int. J. Obes. 2015, 39, 1667–1668. [Google Scholar] [CrossRef] [PubMed]
- Thomas, M.D.; Kyle, K.T.; Stanford, C.F. The gap between expectations and reality of exercise-induced weight loss is associated with discouragement. Prev. Med. 2015, 81, 357–360. [Google Scholar] [CrossRef] [PubMed]
- FDA. Drug Shortages. Available online: https://www.fda.gov/drugs/drug-safety-and-availability/drug-shortages (accessed on 1 June 2024).
- Bajaj, S.S.; Jain, B.; Kyle, K.T.; Gallagher, C.; Stanford, C.F.; Srivastava, G. Overcoming congressional inertia on obesity requires better literacy in obesity science. Obesity 2022, 30, 799–801. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2024 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Northam, K.; Hinds, M.; Bodepudi, S.; Stanford, F.C. The Patient’s Journey in Obesity within the United States: An Exercise of Resilience against Disease. Life 2024, 14, 1073. https://doi.org/10.3390/life14091073
Northam K, Hinds M, Bodepudi S, Stanford FC. The Patient’s Journey in Obesity within the United States: An Exercise of Resilience against Disease. Life. 2024; 14(9):1073. https://doi.org/10.3390/life14091073
Chicago/Turabian StyleNortham, Kayla, Malikiya Hinds, Sreevidya Bodepudi, and Fatima Cody Stanford. 2024. "The Patient’s Journey in Obesity within the United States: An Exercise of Resilience against Disease" Life 14, no. 9: 1073. https://doi.org/10.3390/life14091073